24-Hour Crisis Hotline: (877)SAFEGBC or (877)723-3422 Mental Health & Substance Abuse Issues

6502 Nursery Drive, Suite 100
Victoria, TX 77904
(361)575-0611
Fax: (361)578-5500
Regular Hours: M-Fri 8am - 5pm
Every 3rd Thurs of the Month - Extended Hours Until 7 pm

Medical Disorders
Resources
Basic InformationLookupsLatest News
Even When Undergoing Treatment, People With MS Gain From COVID VaccinesNIH Spending Nearly $470 Million on Long-Haul COVID StudyHospitalizing the Unvaccinated Has Cost U.S. Nearly $6 BillionIn 16 States, 35% or More Residents Now Obese: CDCPet Store Puppies Passing Drug-Resistant Bacteria to PeopleIs a Combo COVID/Flu Shot on the Way?1 in 500 Americans Has Died From COVID-19Having Even a Cousin or Grandparent With Colon Cancer Raises Your Risk: StudyBlood Cancer Patients Could Benefit From COVID Booster Shot: StudyWHO Says Africa Will Get 30% of COVID Vaccines It Needs by FebruaryCOVID Vaccines for Kids Under 12 Could Come This Fall: FauciEbola Vaccine Effective in African Clinical TrialBritain OK's COVID Vaccine for Kids 12 and Older; Hopes to Avoid LockdownsIsraeli Data on COVID Boosters to Be Published This Week in Major JournalData Doesn't Support Need for COVID-19 Vaccine Boosters: ExpertsCOVAX Cuts Global COVID Vaccine Supply Estimates By a QuarterMonth-Long Recovery From Concussion Is Normal: StudyDeath From COVID 11 Times More Likely If You're Unvaccinated: StudyL.A. Is First Major School District to Mandate Vaccines for Students 12 and UpNew Tally Adds Extra 16,000 U.S. Nursing Home Residents Lost to COVIDBlack Americans, Mexican Americans Develop Diabetes Earlier in LifeAverage COVID Hospitalization Is 150 Times More Expensive Than VaccinationGetting Your First COVID Shot Can Boost Mental Health: StudyVaccinated Have 1 in 13,000 Chance of Breakthrough Case Needing HospitalizationBiden Issues Tough New Vaccine Mandates Affecting Millions of U.S. WorkersTime Is Brain: Mobile Stroke Units Reduce Disability, Study FindsWildfires Cause More Than 33,000 Deaths Globally Each YearIs Your Workplace an Asthma Trigger?Biden to Strengthen Push for Vaccine Mandates in New COVID PlanAHA News: How a Simple Tape Measure May Help Predict Diabetes in Black AdultsEczema Can Take Toll on Child's Mental HealthNo Lasting Damage to Lungs After COVID in Young Patients: StudyAdults With Autism, Mental Illness May Be at Higher Risk for Severe COVIDIn Cancer Patients, COVID Vaccine Immunity at 6 Months Is Similar to General PopulationNew Insights Into Why Asthma Worsens at NightHere's How COVID-19 Can Affect Your MouthPet Dogs Can Alert Owners to Epileptic SeizuresU.S. COVID-19 Cases Now Top 40 MillionWhy Aren't COVID Vaccines Getting to People Globally?Which Cancer Patients Need a COVID Booster Shot Most?Few U.S. Workers Know About COVID Sick Leave ProtectionsTherapeutic Brain Implant Won't Alter Personality in Epilepsy Patients: StudyRising Ragweed Levels Mean Fall Allergy Season Is NearVaping Raises Blood Clotting Risks, Harms Small Arteries: StudyMore Than 230 Medical Journals Issue Joint Statement on Health Dangers of Global WarmingAHA News: Clues to Brain Health May Lie in the GutNew COVID Cases Were 300% Higher This Labor Day Weekend Than Last YearWeight Loss Can Help Cut Lung Risks in 9/11 First RespondersHen Hazard: Salmonella a Threat From Backyard ChickensMajor Study Finds No Serious Health Issues From Pfizer, Moderna Vaccines
Questions and AnswersLinks
Related Topics

Diabetes

Data Doesn't Support Need for COVID-19 Vaccine Boosters: Experts

HealthDay News
by Steven Reinberg
Updated: Sep 13th 2021

new article illustration

MONDAY, Sept. 13, 2021 (HealthDay News) -- COVID-19 vaccine booster shots might not be needed for most people, according to a large international review.

The review -- conducted by a team that included scientists from the World Health Organization and the U.S. Food and Drug Administration -- concluded that current vaccines are effective enough against severe COVID-19, even from the Delta variant, and that booster shots are unnecessary.

The findings, published Sept. 13 in The Lancet, are based on a review of all available published literature and results of clinical trials.

"The vaccines that are currently available are safe, effective, and save lives," said study co-author Dr. Soumya Swaminathan, chief scientist at the WHO.

"Although the idea of further reducing the number of COVID-19 cases by enhancing immunity in vaccinated people is appealing, any decision to do so should be evidence-based and consider the benefits and risks for individuals and society," she said in a journal news release. "These high-stakes decisions should be based on robust evidence and international scientific discussion."

According to the review, vaccines were 95% effective against severe disease both from the Delta and Alpha variant, and more than 80% effective at protecting against infection from these variants.

Vaccines are less effective against asymptomatic disease or transmission than against severe disease, according to the review. It added that unvaccinated people are the major drivers of transmission and are at the greatest risk of severe disease.

"Taken as a whole, the currently available studies do not provide credible evidence of substantially declining protection against severe disease, which is the primary goal of vaccination," said lead author Dr. Ana Maria Henao-Restrepo, a medical officer at the WHO's Initiative for Vaccine Research.

She said the limited supply of vaccine will save the most lives if made available to unvaccinated people who are at risk of serious disease.

"Even if some gain can ultimately be obtained from boosting, it will not outweigh the benefits of providing initial protection to the unvaccinated," Henao-Restrepo added. "If vaccines are deployed where they would do the most good, they could hasten the end of the pandemic by inhibiting further evolution of variants."

Although antibodies in vaccinated people wane over time, the authors noted that it does not predict that a lack of protection against severe disease.

Protection against severe disease is not only from antibody responses, which might be short-lived for some vaccines, but also by memory responses and cell immunity, which are longer-lived, the researchers explained. If boosters are needed, they would be in circumstances where the benefits outweigh the risks.

Even without any loss of effectiveness, however, increasing success in delivering vaccines to large populations will lead to increasing more widespread immunization, the researchers said. As a result, more cases that do occur would be less severe breakthrough infections, especially if vaccination leads people to change their behavior.

But, they added, the ability of vaccines to elicit an antibody response against current variants indicates that these variants have not yet evolved so much they are likely to escape the protection by the vaccines.

If boosters are needed, the researchers said, they would most likely be developed against specific variants not covered by current vaccines. This strategy is like that for flu shots, which changes as flu strains evolve from year to year.

More information

There's more about COVID-19 vaccines at the U.S. Centers for Disease Control and Prevention.

SOURCE: The Lancet, news release, Sept. 13, 2021